Potential Molecular Cross Talk Among CCR5 Pathway Predicts Regorafenib Responsiveness in Metastatic Colorectal Cancer Patients

Background: Genetic variants in the CCL5/CCR5 pathway have been shown to predict regorafenib efficacy in patients with metastatic colorectal cancer (mCRC). This study investigated the biological role of CCL4 and CCL3 gene polymorphisms in patients with refractory mCRC treated using regorafenib. Pati...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer Genomics Proteomics
Huvudupphovsmän: SUENAGA, MITSUKUNI, ZHANG, WU, MASHIMA, TETSUO, SCHIRRIPA, MARTA, CAO, SHU, OKAZAKI, SATOSHI, BERGER, MARTIN D., MIYAMOTO, YUJI, BARZI, AFSANEH, YAMAGUCHI, TOSHIHARU, LENZ, HEINZ-JOSEF
Materialtyp: Artigo
Språk:Inglês
Publicerad: International Institute of Anticancer Research 2021
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC8126324/
https://ncbi.nlm.nih.gov/pubmed/33893084
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20262
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk